|
L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Suppliers list
|
| Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
| Tel: |
0513-66337626 18051384581 |
| Email: |
sales@chemhifuture.com |
| Products Intro: |
Product Name:DGN549-L CAS:1884276-68-9 Package:10mg,100mg,500mg,1g,2g,5g,10g,More
|
|
| | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Basic information |
| Product Name: | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- | | Synonyms: | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]-;DGN549-L | | CAS: | 1884276-68-9 | | MF: | C58H58N8O13 | | MW: | 1075.13 | | EINECS: | | | Product Categories: | | | Mol File: | 1884276-68-9.mol | ![L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Structure](CAS/20210305/GIF/1884276-68-9.gif) |
| | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | pka | 13.28±0.70(Predicted) |
| | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Usage And Synthesis |
| Uses | DGN549-L is a DNA alkylator and can be utilized for antibody conjugation at lysine residues. DGN549-L can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. | | References | [1] Bai C, et al. Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation. Bioconjug Chem. 2020;31(1):93-103. DOI:10.1021/acs.bioconjchem.9b00777 |
| | L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]- Preparation Products And Raw materials |
|
|
Tag:L-Alaninamide, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,6-dioxohexyl]-L-alanyl-N-[3-[[[(12aS)-12a,13-dihydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]-5-[[[(12aS)-11,12,12a,13-tetrahydro-8-methoxy-6-oxo-6H-indolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]methyl]phenyl]-(1884276-68-9)
Related Product Information
|